HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal.

Abstract
Elimination of both alleles of the gene that encodes the cyclin kinase inhibitor p21(WAF1/cip1) increases the frequency and size of intestinal tumors in Apc1638+/- mice that inherit a mutant allele of the Apc gene, and intermediate effects are seen if a single p21 allele is inactivated. The increased tumor formation is associated with altered cell maturation in the intestinal mucosa of the p21-deficient mice--increased cell proliferation, and decreased apoptosis, and goblet cell differentiation--that is also a function of p21 gene dosage. Moreover, a Western-style diet that mimics principal risk factors for colon cancer (high fat and phosphate, low calcium and vitamin D) accelerates tumor formation in Apc1638+/- mice, and the loss of a single or both p21 alleles is additive with the tumor-promoting effects of this diet, resulting in more and larger tumors, and a highly significant decrease in survival time. Thus, p21 normally suppresses Apc-initiated tumor formation and is haplo-insufficient in this regard. This is consistent with recent reports that Apc initiates tumor formation by up-regulating c-myc expression through altered beta-catenin-Tcf signaling and that c-myc then up-regulates cdk4, whose activity is inhibited by p21. Decreased expression of p21 is also a marker of poor prognosis in patients, and the data presented suggest that dietary alterations in patients undergoing treatment for colon cancer might be highly effective in improving outcome.
AuthorsW C Yang, J Mathew, A Velcich, W Edelmann, R Kucherlapati, M Lipkin, K Yang, L H Augenlicht
JournalCancer research (Cancer Res) Vol. 61 Issue 2 Pg. 565-9 (Jan 15 2001) ISSN: 0008-5472 [Print] United States
PMID11212250 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Adenomatous Polyposis Coli Protein
  • Cdkn1a protein, mouse
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Cytoskeletal Proteins
  • Mucins
  • Proliferating Cell Nuclear Antigen
Topics
  • Adenomatous Polyposis Coli Protein
  • Animals
  • Apoptosis
  • Cell Differentiation (genetics)
  • Cell Division (genetics)
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins (genetics)
  • Cytoskeletal Proteins (genetics)
  • Diet (adverse effects)
  • Female
  • Gastrointestinal Neoplasms (etiology, genetics, pathology)
  • Gene Silencing
  • Genotype
  • Immunohistochemistry
  • Intestinal Mucosa (chemistry, metabolism, pathology)
  • Male
  • Mice
  • Mice, Mutant Strains
  • Mucins (analysis)
  • Mutation
  • Proliferating Cell Nuclear Antigen (analysis)
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: